TriSalus Life Sciences Inc. (NASDAQ: TLSI)
$4.9400
+0.1600 ( +0.31% ) 0.0K
TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.
Market Data
Open
$4.9400
Previous close
$4.7800
Volume
0.0K
Market cap
$145.76M
Day range
$4.9250 - $4.9250
52 week range
$3.5000 - $10.4200
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Aug 21, 2024 |
| 8-k | 8K-related | 15 | Aug 15, 2024 |
| 10-q | Quarterly Reports | 88 | Aug 14, 2024 |
| ars | Annual reports | 1 | Jul 19, 2024 |
| def | Proxies and info statements | 14 | Jul 19, 2024 |
| 4 | Insider transactions | 1 | Jul 02, 2024 |
| 8-k | 8K-related | 15 | Jul 01, 2024 |
| 8-k | 8K-related | 16 | Jun 27, 2024 |
| 4 | Insider transactions | 1 | Jun 05, 2024 |
| 8-k | 8K-related | 15 | May 24, 2024 |